Bacterial Infections (Bacterial Infection)

1.	Infection
2.	Neoplasms (Cancer)
3.	Hemorrhage
4.	Neutropenia
5.	Pneumonia (Pneumonitis)
634 Diseases and 2220 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Experts

1.	Perry, Caroline M: 4 articles (01/2008 - 01/2002)
2.	Smirnova, L B: 4 articles (01/2003 - 01/2000)
3.	Müller, Beat: 3 articles (09/2008 - 08/2005)
4.	Keam, Susan J: 3 articles (01/2008 - 01/2005)
5.	Neuhaus, Peter: 3 articles (07/2007 - 01/2005)
6.	Rayes, Nada: 3 articles (07/2007 - 01/2005)
7.	Seehofer, Daniel: 3 articles (07/2007 - 01/2005)
8.	Roberts, Jenny R: 3 articles (06/2007 - 11/2003)
9.	Castranova, Vincent: 3 articles (06/2007 - 11/2003)
10.	Antonini, James M: 3 articles (06/2007 - 11/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Bacterial Infections:

1.	Anti-Bacterial Agents (Antibiotics)IBA 08/01/2008 - "This study suggests that GSPBRT-PCR is very useful for the rapid and accurate diagnosis of bacterial infection and that it can have an important impact on the current inappropriate and unnecessary use of antibiotics in the treatment of newborns." 08/01/1988 - "A significantly greater proportion (4.5%) of subsequent bacterial infections occurred in infants who received parenteral antibiotics (p = 0.01), and especially in a subgroup who received parenteral antibiotics for 5 or more days (11%, p less than 0.001)" 08/01/1996 - "Treatment of bacterial infections has become more effective with the advent of broad-spectrum antibiotics; however, the dreadful emergence of polyresistant strains may be a serious problem in the near future" 04/01/1991 - "Empirical treatment with a combination of antibiotics has been shown in comparative studies to be effective in initial management of the febrile neutropenic patient: continuing studies are evaluating the role of monotherapy and of different antibiotic combinations, particularly in the light of changing patterns of bacterial infections" 09/13/2005 - "Many antibiotics that were formerly effective in combating bacterial infections in hospital patients are no longer effective because of the evolution of resistant strains, which compromises medical care worldwide" Get all the results and reference details, order at left...
2.	Ciprofloxacin (Cipro)FDA LinkGeneric 03/01/1991 - "Ciprofloxacin appears to be effective for preventing bacterial infections in neutropenic patients" 12/11/1987 - "Prolonged administration of ciprofloxacin turned out to be safe and effective in preventing serious aerobic bacterial infections during the first three months after BMT." 01/01/2003 - "Clinical efficacy of ciprofloxacin 0.3%9 (Ciloxan) in the treatment of bacterial infections of the external eye segment]" 04/01/1989 - "Efficacy of ciprofloxacin in the treatment of various bacterial infections." 05/01/2001 - "This study reports on the biodistribution and dosimetry of technetium-99m ciprofloxacin, a radio-ligand developed for the visualisation of bacterial infection" Get all the results and reference details, order at left...
3.	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/01/1983 - "Ceftriaxone given in a 24-hourly regimen is convenient and highly effective in serious bacterial infections in children and is without significant toxicity." 05/01/1997 - "Once daily infusion of ceftriaxone therefore seems to be effective in the treatment of severe bacterial infections in Chinese patients." 11/01/1984 - "Ceftriaxone (Ro 13-9904, CTRX) was evaluated in 20 children with a suspicion of bacterial infections, 18 were shown to be effective (efficacy rate, 90%)" 11/01/1996 - "Ceftriaxone may be useful in the treatment of bacterial infections in horses" 03/01/1982 - "Our findings suggest that ceftriaxone is a safe and effective antibiotic for therapy of serious bacterial infections." Get all the results and reference details, order at left...
4.	Norfloxacin FDA Link 06/15/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the eyelids or conjunctiva, or both" 01/01/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the lids and/or conjunctiva" 05/01/1992 - "The aim of the study has been to assess if intermittent treatment with norfloxacin could be able to maintain selective intestinal decontamination in cirrhotic patients in order to prevent bacterial infections" 08/01/1999 - "Three bacterial infections in patients from Group I, 3 from Group II patients receiving norfloxacin and 16 from Group II patients not receiving norfloxacin were recorded (p<0.05)" 06/26/1987 - "Norfloxacin for prevention of bacterial infections in granulocytopenic patients." Get all the results and reference details, order at left...
5.	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric 12/24/1992 - "The time to a first bacterial infection was significantly greater for those assigned to trimethoprim-sulfamethoxazole (P = 0.017)" 04/01/1990 - "Several trials showed that cotrimoxazole was effective for the prevention of bacterial infection: thus, this antimicrobial can be used as long-term and continuous prophylaxia" 08/01/1991 - "Prophylactic co-trimoxazole was effective in reducing the frequency of bacterial infections" 06/01/1998 - "In conclusion, the results of the study suggest that TMP-SMX appears to be a valuable alternative to P-S, in particular in patients with opportunistic bacterial infections." 06/01/1996 - "Bacterial infection during the 3-month study period occurred in 11 control patients but in only 2 patients assigned TMP-SMX (P = 0.004)" Get all the results and reference details, order at left...
6.	AntibodiesIBA 01/01/1987 - "It is highly immunogenic in mice and most murine strains have circulating anti-PC antibodies which are known to confer protection against certain bacterial infections" 01/01/1998 - "These results suggest that antibodies in low-heat skim milk, which still have reactivity to exogenous or indigenous bacteria, may contribute to the protective effects against bacterial infection." 01/01/2005 - "Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies." 03/01/1990 - "Interestingly, the protection against the bacterial infection was accompanied by only a minor increase in specific serum antibodies against F5'EP-Sm" 10/12/1995 - "The detection and quantitation of anti-LPS antibodies has formed the basis of classical and more recent serological studies of major bacterial infections." Get all the results and reference details, order at left...
7.	Intravenous Immunoglobulins (IVIG)FDA Link 03/01/1993 - "In addition, the current studies do not establish the efficacy of IVIg for either treating or preventing neonatal bacterial infections" 11/01/2006 - "Efficacy of intravenous immunoglobulins in bacterial infections]" 07/01/1994 - "IVIG therapy may also reduce the mortality and incidence of bacterial infections in adults but further studies are required" 06/01/1994 - "In patients who received placebo during the original study, the rate of serious bacterial infections was significantly lower after change to open label IVIG (estimated 15.8 fewer episodes/100 patient years; 95% confidence interval, 3.2 to 28.5; P = 0.014)" 04/01/1991 - "In both studies, serious bacterial infections were considerably reduced by IVIg" Get all the results and reference details, order at left...
8.	Immunoglobulins (Immunoglobulin)IBA 02/01/1997 - "The efficacy of intravenous immunoglobulin (i.v.IG) is questionable because the prophylactic and therapeutic administration of i.v.IG fails to reduce the incidence of bacterial infections or affect the overall survival rate" 12/01/1991 - "Intravenous gamma immunoglobulin demonstrated to be effective in preventing bacterial infections and decreasing the number of hospitalizations in a subgroup of children infected with HIV." 06/01/1994 - "Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children" 07/01/1983 - "Efficacy of intravenous immunoglobulin preparations against viral and bacterial infections in mouse protection tests." 01/01/1980 - "Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections]" Get all the results and reference details, order at left...
9.	Gentamicins (Gentamicin)FDA LinkGeneric 01/01/2004 - "After infection, bacterial cells that remain extracellular are eliminated with gentamicin" 01/22/2007 - "Searching for more effective treatments, this study was designed to evaluate biodegradable injectable gelling polymeric devices for the controlled release of gentamicin sulfate in the treatment of invasive bacterial infections" 02/27/2008 - "Gentamicin (GM), an antibiotic against life threatening bacterial infection, induces remarkable toxicity in the kidney" 11/01/2007 - "Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections." 10/01/2007 - "Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants." Get all the results and reference details, order at left...
10.	VaccinesIBA 04/01/1975 - "It appears that, although the HPC line is more effective in its defense against bacterial infections, the LPC line can be aided more by vaccines." 10/26/2004 - "The lipidated vaccines, but not the nonlipidated vaccines, were able to mediate protection against viral or bacterial infection and mediate prophylactic and therapeutic anticancer activity" 06/01/2007 - "Intranasal vaccines for protection against respiratory and systemic bacterial infections." 12/01/2008 - "Our report provides a unifying framework to compare killing efficacies of CD8 T-cell responses specific to different viral and bacterial infections in vivo, which may be used to compare efficacies of various cytotoxic-T-lymphocyte-based vaccines." 09/18/2008 - "Results obtained from the application of these new methods are forming a basis for a new generation of vaccines for use in the control of bacterial infections of humans and animals." Get all the results and reference details, order at left...
1640 Drugs and Important Bio-Agents and 5634 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 11/01/2005 - "Development of therapeutic standards in bacterial infections on the basis of pharmacoeconomic analyses and clinical studies determining effectiveness and safety of therapy allows for more rational pharmacotherapy" 11/01/2005 - "Development of therapeutic standards in bacterial infections on the basis of pharmacoeconomic analyses and clinical studies determining effectiveness and safety of therapy allows for more rational pharmacotherapy" 01/08/1979 - "Prospects for bacteriological studies and chemotherapy of bacterial infections]" 05/01/2006 - "Considering patients (n=8) with documented bacterial infection between cycles, the number of migrated neutrophils (mean+/-SD) compared to response at diagnosis was markedly reduced upon chemotherapy to either fMLP (30.1+/-8.26 vs. 2.81+/-1.28) or LTB(4) (15.72+/-4.8 vs. 2.8+/-1.64) stimuli respectively" 03/01/2005 - "Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT." Get all the results and reference details, order at left...
2.	Transplants (Transplant) 04/01/1985 - "Two patients had bacterial infections during the period of study, and one patient experienced a short-lived readily reversible rejection of a corneal transplant" 10/01/2008 - "We hypothesized that increased vascularity around a prosthetic graft may exert a preventive role against bacterial infection" 08/28/2008 - "Opportunistic bacterial infections are uncommon after 6 mo in patients receiving stable and reduced maintenance doses of immunosuppression with good graft function and little is documented about these cases in the literature" 08/28/2008 - "Bacterial infections occurring early after transplant are mainly related to the technical aspects of the procedure" 08/01/2008 - "Two out of seven patients developed bacterial infections in the early post transplant period" Get all the results and reference details, order at left...
3.	Antibiotic Prophylaxis 06/21/2005 - "Trials have shown the efficacy of antibiotic prophylaxis in decreasing the incidence of bacterial infections but not in reducing mortality rates" 01/01/2005 - "Trials have shown the efficacy of antibiotic prophylaxis in decreasing the incidence of bacterial infections, but not in reducing mortality rates" 02/01/2003 - "Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials." 10/15/2006 - "New evidence shows that antibiotic prophylaxis in neutropenic patients reduces mortality, febrile episodes, and bacterial infections" 10/01/2006 - "On multivariate analysis, antibiotic prophylaxis (relative hazard: 0.248, 95% confidence interval (CI): 0.067-0.919, p=0.037) and bacterial infection (relative hazard: 3.901, 95% CI: 1.053-14.448, p=0.042) were two independent determinants of early rebleeding" Get all the results and reference details, order at left...
4.	Homologous Transplantation (Allograft) 06/01/1993 - "It appears, from this study, that rejection of the lung allograft results in alterations in BAL lymphocyte phenotypes and functions that differ from those associated with bacterial infection" 05/01/2008 - "Bacterial infections are common in the perioperative period of solid organ allograft recipients in the clinic, and correlations between bacterial infections and acute allograft rejection have been reported" 11/01/2005 - "This method of processing appears to be associated with a very low risk of allograft-related bacterial infection." 07/01/2005 - "The antibiotic permeable cryopreserved homograft has proven to be resistant to biofilm bacterial infection." 04/03/2002 - "Update: allograft-associated bacterial infections--United States, 2002." Get all the results and reference details, order at left...
5.	Cardiopulmonary Resuscitation (CPR) 02/01/1991 - "These findings indicate that CPR is useful for the treatment of bacterial infections in children." 02/01/1991 - "The data indicate that CPR is safe and effective, when used in children with susceptible bacterial infections." 02/01/1991 - "3. Clinical results Evaluation of clinical effects of CPR on various types of bacterial infections was conducted in 56 subjects, excluding 3 subjects who had diseases which were excluded from the study" 10/01/2001 - "OBJECTIVE: To compare the diagnostic performance of PCT in the early detection of invasive bacterial infection in infants with that of CPR" 04/01/2001 - "Therefore, an increase in CPR activity may facilitate rapid inactivation of these inflammatory mediators generated at the site of bacterial infection" Get all the results and reference details, order at left...
193 Therapies and Procedures and 1055 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Patient-Physician
Research Summary Report
on Bacterial Infections

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 376 Outcomes
Top 200 Key Medications
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF for "Psoriasis" >>

Price:

$24.00 & Delivery via PDF download,
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>